Kanoria Chemicals & Industries shares hit a day high of Rs 187.80 on 13 Nov, the day it reported a 258% jump in standalone Q2 net profit.

The results cover July to September 2026. The company earned a standalone net profit of about Rs 23.3 crore, against Rs 6.5 crore in the same quarter last year.

Standalone means the figures for the company alone, without its subsidiaries. Sales also grew, by about 71.5% from a year earlier.

The company kept more of each rupee too. Its operating margin rose to 12.4% from 11.2%.

Put simply, out of every Rs 100 in sales, about Rs 12.40 was left as operating profit, up from Rs 11.20. The board also met on 13 November.

It approved a fresh three-year term for Rajya Vardhan Kanoria as Managing Director, starting 10 January 2027. Shareholders still need to approve it.

There was a pattern to the numbers before this too. In the April to June quarter, the company’s standalone net profit was Rs 26.36 crore.

On 7 October, the company told exchanges it had started a new plant at its Ankleshwar site in Gujarat.

The unit makes 12 tonnes of Triacetin a day. It is a chemical used in food, medicines, plastics, coatings and adhesives.

By the close, the stock settled at Rs 183.96 on NSE, up Rs 4.14 or 2.30% from the previous day.

That is about 13.99% higher than a week ago. NSE shows a 52-week range of Rs 56.00 to Rs 206.00, and the company’s market value stands at about Rs 803.78 crore.

Want a clearer plan for your next intraday trade? Get research-backed recommendations with entry levels, targets, stop-losses and timely updates. Download the Intraday Traders by EquityPandit app and get started.